Researchers from the University of Cambridge, in “collaboration with researchers at the Universities of Kent, Oxford and Liverpool”, decided to test “for evidence of the production of ‘off-target’ proteins in people who received the mRNA Pfizer vaccine against COVID-19”.
This might be another important mechanism responsible for disease enhancement in individuals who become infected around the time of the first dose.